Change over period: —
NSE · EMAMILTD
EMAMI LTD.
-24.4% from the 52-week high · +14.7% above the low
Emami Ltd. engages in the marketing and sale of medicinal, cosmetics, and toiletries products. The company is headquartered in Kolkata, West Bengal and currently employs 3,235 full-time employees. The company went IPO on 2006-08-03. The firm is engaged in the business of manufacturing health, beauty and personal care products. The Company’s brands, including BoroPlus, Navratna, Zandu, Fair and Handsome, Kesh King, Mentho plus balm, Dermicool, 7 Oils in One, HE, Diamond Shine, Emami Golden Beauty, Emami Naturally Fair, Emami Emasol and Creme21. The company has a portfolio of over 300 + products based on ayurvedic formulations. Its operations comprise more than 60 countries, including SAARC, MENAP, SEA, Africa, Eastern Europe and the CIS countries. The company provides Ayurvedic Antiseptic Cream, Prickly Heat Powder, Doodh Kesar Body Lotion, Vasocare Herbal Petroleum Jelly, Aloe Vera Gel, Hygiene Range, Cool Oil, Extra Thanda, Gold Ayurvedic Oil and others. The company has manufacturing units in India and abroad to develop products suited to meet the diverse needs and preferences of consumers in different markets.
The short version. EMAMI LTD. reported revenue of ₹1,039 crore for Jun 2026, up 14.9% from a year earlier. Net profit was ₹137 crore (down 16.5% year on year). Return on equity was 26.5% in Mar 2026. Promoter holding was 54.84% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
EMAMI LTD. trades 24.4% below its 52-week high and 14.7% above its 52-week low.
2 · The business
Is it growing?
Jun 2026 revenue of ₹1,039 cr.
Jun 2026 net profit of ₹137 cr.
5.0 pts lower than a year earlier.
Revenue compounded at 3.6% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1039 | 925 | 1152 | 799 | 904 | 963 | 1049 | 891 |
| Net profit | 137 | 143 | 319 | 148 | 164 | 162 | 279 | 213 |
| Net margin % | 13.2 | 15.5 | 27.7 | 18.6 | 18.2 | 16.8 | 26.6 | 23.9 |
| EPS (₹) | 3.15 | 3.28 | 7.32 | 3.4 | 3.76 | 3.72 | 6.39 | 4.87 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3780 | 3809 | 3578 | 3406 | 3192 | 2881 | 2655 | 2693 |
| Net profit | 775 | 806 | 724 | 640 | 839 | 455 | 303 | 303 |
| Net margin % | 20.5 | 21.2 | 20.2 | 18.8 | 26.3 | 15.8 | 11.4 | 11.3 |
| EPS (₹) | 17.76 | 18.48 | 16.58 | 14.5 | 19.02 | 10.23 | 6.67 | 6.68 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 26.5% in Mar 2026; debt to equity is 0.04.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 26.5 | 29.9 | 29.6 | 27.8 |
| Return on capital % | 28.7 | 33.2 | 31.9 | 28.7 |
| EBITDA margin % | 26.9 | 28.2 | 27.3 | 26.8 |
| Net margin % | 20.1 | 20.8 | 20.0 | 18.4 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 3.6% | 5.5% |
| Profit CAGR | 6.6% | 11.3% |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 5.09 pts over 8 quarters.
Up 1.88 pts over 8 quarters.
+12 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 54.84 | 54.84 | 54.84 | 54.84 | 54.84 | 54.84 | 54.84 | 54.84 | 0.0 |
| FII | 14.11 | 12.11 | 11.89 | 10.93 | 9.03 | 8.58 | 7.87 | 9.02 | -5.09 |
| DII | 21.7 | 23.67 | 24.06 | 25.01 | 26.73 | 26.92 | 27.01 | 23.58 | +1.88 |
| Public | 9.35 | 9.37 | 9.2 | 9.21 | 9.39 | 9.66 | 10.27 | 12.56 | +3.21 |
Mutual fund holdings · Oct 2026
111 schemes hold this stock
99 the month before.
- Kotak Rural Opportunities Fund3.83% of NAV
- Bank of India Consumption Fund2.3% of NAV
- DSP Nifty Smallcap250 Quality 50 Index Fund2.28% of NAV
- Sundaram Value Fund1.85% of NAV
- DSP Aggressive Hybrid Fund1.5% of NAV
- Templeton India Value Fund1.42% of NAV
- NJ Flexi Cap Fund1.4% of NAV
- DSP Value Fund1.14% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for EMAMI LTD. are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Personal Products stocks
Quick answers
Common questions about EMAMI LTD.
What is the EMAMI LTD. share price?
EMAMI LTD. (EMAMILTD) last closed at ₹422.95, up 2.46% on the day. Its 52-week range is ₹359.75 to ₹545.75.
What is the market cap of EMAMI LTD.?
EMAMI LTD. has a market capitalisation of about ₹18,001 crore. Its price-to-earnings ratio is 24.0.
How are EMAMI LTD.'s latest results?
EMAMI LTD. reported revenue of ₹1,039 crore for Jun 2026, up 14.9% from a year earlier. Net profit was ₹137 crore (down 16.5% year on year). Return on equity was 26.5% in Mar 2026. Promoter holding was 54.84% in Sep 2026, up 0.00 points over 8 quarters.
Who owns EMAMI LTD.?
As of Sep 2026, shareholding was: Promoter 54.84%, FII 9.02%, DII 23.58%, Public 12.56%.
How many mutual funds hold EMAMI LTD.?
111 mutual fund schemes held EMAMI LTD. in October 2026. That compares with 99 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 10 Feb 2026 · Interim Dividend - Rs. 6
- 14 Nov 2025 · Interim Dividend - Rs. 4
- 22 May 2025 · Special Dividend - Rs. 2
- 04 Feb 2025 · Interim Dividend - Rs. 4
- 18 Nov 2024 · Interim Dividend - Rs. 4
- 16 Feb 2024 · Interim Dividend - Rs. 4
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.